Rejected at 8:32 p.m. Oct, 31, 2023 ] by dollajas
Author: a.acharya
Related Note: 1496008817614
Rationale for change

Premedication to prevent hypersensitivity of taxanes

Rejection reason

no source & low yield if true

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::09_Drug_reactions-neurologic #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::02_DNA_&_Cellular_Division::05_Mitotic_Inhibitors::zanki_extra #AK_Step2_v12::#SketchyIM::05_Endocrinology::01_Diabetes_Mellitus::03_Chronic_Diabetes_Complications_SOAP #AK_Other::Only_Step_1 #AK_Step1_v12::#Bootcamp::Biochemistry::01_Cell_Biology::06_Cytoskeleton #AK_Step1_v12::#B&B::12_Hematology::04_Cancer_Drugs::04_Microtubule_Inhibitors #AK_Other::^EXPN #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::15_Microtubule_inhibitors::*Taxanes #AK_Step1_v12::#OME_banner #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::10_Taxanes